- Home
- VERV vs FMTO Comparison
VERV vs FMTO Comparison
Compare VERV & FMTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- FMTO
- Stock Information
- Founded
- VERV 2018
- FMTO 2000
- Country
- VERV United States
- FMTO Israel
- Employees
- VERV N/A
- FMTO N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- FMTO
- Sector
- VERV Health Care
- FMTO
- Exchange
- VERV Nasdaq
- FMTO NYSE
- Market Cap
- VERV 384.2M
- FMTO 3.0M
- IPO Year
- VERV 2021
- FMTO N/A
- Fundamental
- Price
- VERV $4.45
- FMTO $4.12
- Analyst Decision
- VERV Strong Buy
- FMTO
- Analyst Count
- VERV 6
- FMTO 0
- Target Price
- VERV $25.75
- FMTO N/A
- AVG Volume (30 Days)
- VERV 2.9M
- FMTO 40.5K
- Earning Date
- VERV 05-14-2025
- FMTO 05-15-2025
- Dividend Yield
- VERV N/A
- FMTO N/A
- EPS Growth
- VERV N/A
- FMTO N/A
- EPS
- VERV N/A
- FMTO N/A
- Revenue
- VERV $59,613,000.00
- FMTO $620,978.00
- Revenue This Year
- VERV $6.18
- FMTO N/A
- Revenue Next Year
- VERV N/A
- FMTO N/A
- P/E Ratio
- VERV N/A
- FMTO N/A
- Revenue Growth
- VERV 271.44
- FMTO N/A
- 52 Week Low
- VERV $2.87
- FMTO $4.10
- 52 Week High
- VERV $9.31
- FMTO $7,225.00
- Technical
- Relative Strength Index (RSI)
- VERV 47.78
- FMTO N/A
- Support Level
- VERV $3.89
- FMTO N/A
- Resistance Level
- VERV $4.63
- FMTO N/A
- Average True Range (ATR)
- VERV 0.41
- FMTO 0.00
- MACD
- VERV 0.02
- FMTO 0.00
- Stochastic Oscillator
- VERV 47.06
- FMTO 0.00
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About FMTO FEMTO TECHNOLOGIES INC
Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.